Tag: Middle income countries
Why Investors in the Pharmaceutical Industry Should Start Investing in Diseases Affecting Poor Countries.
Let’s discuss why investors in the pharmaceutical industry should start investing in drugs, therapeutics and medical devices aimed at treating, managing and ameliorating diseases affecting middle income countries in particular and the ‘global south’ in general.
T
The Basics: The Paradox of the Dual Burden – NCDs and CDs
Here’s a fictional allegory: Thelma lives in a rural area in Tanzania. At age 5, she contracted malaria. Due to broadened availability of health services, Thelma received an artemisinin based treatment and, unlike many before her, she survived. In fact, she lived a long, healthy life. Long enough to reach the age of 55; at ...
Global Health Conversations 